EyeGate Pharmaceuticals vs Ray Therapeutics
EyeGate Pharmaceuticals vs Ray Therapeutics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: EyeGate Pharmaceuticals is on 32/100 and Ray Therapeutics on 53/100.
Where each one leads
EyeGate Pharmaceuticals
- agent readiness: 39/100 against 21/100
- domain rating: 34/100 against 29/100
Ray Therapeutics
- our overall score: 53/100 against 32/100
- funding raised: $243M against $45.5M
At a glance
| Measure | EyeGate Pharmaceuticals | Ray Therapeutics |
|---|---|---|
| What it is | Clinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases. | Pioneering vision restoration therapies for severe retinal degenerations. |
| Category | Biotech, MedTech, HealthTech, Drug Discovery | Biotechnology, Pharmaceuticals, Healthcare, Medical Devices |
| Sells toBusiness model | B2B | B2C | B2B2C | B2G | B2B |
| Offering | Software | hardware | services | marketplace | platform | Services |
| Founded | 2000 | 2021 |
| Headquarters | Waltham, United States | Berkeley, USA |
| Status | Active | Active |
Size, funding and growth
| Measure | EyeGate Pharmaceuticals | Ray Therapeutics |
|---|---|---|
| Total funding | $45.5M | $243M |
| Latest round | Debt | Series B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | EyeGate Pharmaceuticals | Ray Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 32/100 | 53/100 |
| Traction | 38/100 | 40/100 |
| Team | 30/100 | 50/100 |
| Search visibility | 5/100 | 14/100 |
| Quality | 35/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | F (21/100) |
| Domain ratingLink authority, 0-100 | 34/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | EyeGate Pharmaceuticals | Ray Therapeutics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Google Analytics 4, Google Tag Manager | Google Analytics 4 |
EyeGate Pharmaceuticals vs Ray Therapeutics: common questions
Which is better, EyeGate Pharmaceuticals or Ray Therapeutics?
On our 0-100 score Ray Therapeutics rates higher (53/100 against 32/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do EyeGate Pharmaceuticals and Ray Therapeutics compare on the numbers?
EyeGate Pharmaceuticals leads on agent readiness (39/100 against 21/100), domain rating (34/100 against 29/100). Ray Therapeutics leads on our overall score (53/100 against 32/100), funding raised ($243M against $45.5M).
Read the full EyeGate Pharmaceuticals review and pricing or the Ray Therapeutics review and pricing. You can also browse other EyeGate Pharmaceuticals alternatives we track.